Authors: Zhou, Q Hopp, T Fuqua, SAW Steeg, PS

Citation: Q. Zhou et al., Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment, CANCER LETT, 162(1), 2001, pp. 3-17

Authors: Wang, CG Fu, MF Angeletti, RH Siconolfi-Baez, L Reutens, AT Albanese, C Lisanti, MP Katzenellenbogen, BS Kato, S Hopp, T Fuqua, SAW Lopez, GN Kushner, PJ Pestell, RG

Citation: Cg. Wang et al., Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity, J BIOL CHEM, 276(21), 2001, pp. 18375-18383

Authors: Oesterreich, S Zhang, QP Hopp, T Fuqua, SAW Michaelis, M Zhao, HH Davie, JR Osborne, CK Lee, AV

Citation: S. Oesterreich et al., Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclearmatrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation, MOL ENDOCR, 14(3), 2000, pp. 369-381

Authors: Fuqua, SAW Wiltschke, C Zhang, QX Borg, A Castles, CG Friedrichs, WE Hopp, T Hilsenbeck, S Mohsin, S O'Connell, P Allred, DC

Citation: Saw. Fuqua et al., A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions, CANCER RES, 60(15), 2000, pp. 4026-4029